PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1370917-10	1992	The high AFP-titer strain (AFPGC-2) showed a marked regression or suppression of tumor growth after administration of both mitomycin C (MMC) and cisplatin (CDDP).	Cisplatin	145-154	alpha fetoprotein	Mus musculus	9-12	
26515460-9	2015	Using a mouse xenograft model we could show a significant decrease of alpha-fetoprotein after combination therapy of oral micellar curcumin and cisplatin.	Cisplatin	144-153	alpha fetoprotein	Mus musculus	70-87	
26401077-13	2015	AST, ALT and AFP levels in serum were significantly lower in the QHF, DDP and QHF plus DDP groups compared to the model control group (P < 0.05).	Cisplatin	70-73	alpha fetoprotein	Mus musculus	13-16	
1370917-10	1992	The high AFP-titer strain (AFPGC-2) showed a marked regression or suppression of tumor growth after administration of both mitomycin C (MMC) and cisplatin (CDDP).	Cisplatin	156-160	alpha fetoprotein	Mus musculus	9-12	
33685316-9	2021	Mice treated with cisplatin-loaded hydrogels exhibited a significant decrease in tumor growth, along with lower plasma AFP levels as compared to hydrogel-treated and untreated tumor-bearing mice.	Cisplatin	18-27	alpha fetoprotein	Mus musculus	119-122